Literature DB >> 7667111

Identification of an enhancer involved in tissue-specific regulation of the rat fibronectin gene.

S A Sporn1, J E Schwarzbauer.   

Abstract

Fibronectin (FN) is a widely distributed extracellular matrix protein that is essential for cell adhesion in a variety of biological processes such as wound healing, tissue development and remodeling and oncogenic transformation. Appropriate FN levels are obtained by induction or repression of the FN gene in response to specific factors or circumstances in vivo. In order to identify regulatory regions involved in tissue-specific expression of FN, we have examined the transcriptional activity of overlapping fragments, within 4 kb upstream of the rat FN gene, following transfection into different cell types. Two regions conferred increases in transcription. The region between -1.08 and -2.6 displayed tissue-specificity and was active in fibroblasts but not hepatoma cells. The second region, between -3.2 and -3.9, was active in both cell types. Further characterization of the -1.08 to -2.6 segment demonstrated that it acts as an enhancer. Exonuclease III deletions of the 3' and 5' ends of the enhancer localized essential sequences between -1.5 and -1.7 and indicate that this fragment acts in concert with other sites between -1.08 and -2.6 to provide maximum enhancer activity. Gel mobility shift assays demonstrated fibroblast-specific binding of nuclear protein(s) to a 65 bp fragment within the essential region and DNase I footprinting localized this binding to a 27 bp sequence. Deletion of the sequence abolished the activity of the 1.5 kb enhancer. These studies show that a novel DNA sequence at -1688 is involved in regulating transcription of the FN gene in fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7667111      PMCID: PMC307196          DOI: 10.1093/nar/23.16.3335

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  34 in total

1.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.

Authors:  R A Ignotz; J Massagué
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

Review 2.  A signature for the HMG-1 box DNA-binding proteins.

Authors:  D Landsman; M Bustin
Journal:  Bioessays       Date:  1993-08       Impact factor: 4.345

3.  Transcriptional control of the fibronectin gene in chick embryo fibroblasts transformed by Rous sarcoma virus.

Authors:  J S Tyagi; H Hirano; G T Merlino; I Pastan
Journal:  J Biol Chem       Date:  1983-05-10       Impact factor: 5.157

4.  Three different fibronectin mRNAs arise by alternative splicing within the coding region.

Authors:  J E Schwarzbauer; J W Tamkun; I R Lemischka; R O Hynes
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

5.  Cloning and analysis of the promotor region of the human fibronectin gene.

Authors:  D C Dean; C L Bowlus; S Bourgeois
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

6.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

Authors:  B B Knowles; C C Howe; D P Aden
Journal:  Science       Date:  1980-07-25       Impact factor: 47.728

7.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Multiple regulatory elements in the intergenic region between the alpha-fetoprotein and albumin genes.

Authors:  R Godbout; R Ingram; S M Tilghman
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

10.  Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene.

Authors:  A R Kornblihtt; K Umezawa; K Vibe-Pedersen; F E Baralle
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.